LOGO
LOGO

Adicet To Report Initial Data From Lupus Nephritis, Clear Cell Renal Cell Carcinoma Trials In 1H2025

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News
rttnewslogo20mar2024

Adicet Bio Inc. (ACET), a clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, has key clinical trial events to watch in 2025.

The company has two investigational drugs in clinical development - ADI-001 and ADI-270.

Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe Now
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - May 04 – May 08, 2026

May 08, 2026 15:50 ET
Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.

Latest Updates on COVID-19